

Each 0.1 ml dose contains: Piscirickettsia salmonis (SRS) and Infectious Pancreatic Necrosis Virus (IPN); Non-mineral oily adjuvant; Excipients q.s. to 0.1 ml.
Active immunization as an aid in the prevention of Infectious Pancreatic Necrosis (IPN) and Salmon Rickettsial Syndrome (SRS) in Atlantic Salmon, Coho Salmon and Rainbow Trout.
2-dose vaccination schedule: First dose: 0.05 ml, between 5-15 grams. Booster: 0.1 ml, from 20 grams. Single dose vaccination schedule: 0.1 ml, starting at 20 grams.
Physiological condition: pre-smolt, in fresh water. Route of administration: intraperitoneal.
Instructions for use: It is recommended to leave the fish fasting for at least 48 hours prior to vaccination.
Fish should be anesthetized before vaccination. Shake before use. Apply aseptic technique for administration.
Do not vaccinate fish weighing less than 5 or 20 grams, depending on the selected vaccination scheme.
Do not vaccinate sick, weak or stressed fish. Do not vaccinate brood fish.
Do not vaccinate fish when the water temperature is higher than 15°C.
Do not vaccinate during smoltification.
Do not transfer the fish to the sea before 500 ATU post vaccination. Keep out of reach of children and domestic animals. Occasionally, mild, transient adhesions and pigmentation of the abdominal cavity may occur after vaccination.
Accidental injection of the oily emulsion may result in localized pain or allergic reaction. Seek medical advice. Avoid contact of the product with skin and eyes.
250 ml (2500 doses of 0.1 ml).
Use the entire contents of the container once opened.
Do not store bottles with any remaining unused product.
Incineration is recommended for disposal of packaging and waste.
Keep out of reach of children. In case of accident with the product, contact the National Poison Control Center (In Argentina, telephone: 0800-333-0160). Do not subject animals to excessive work or herding before and after vaccination. Do not administer to parasitized, malnourished, fatigued, feverish animals, or animals under antibiotic and/or corticosteroid treatment.
Administer this product under veterinary supervision. The product may cause a slight local reaction at the injection site that gradually disappears. In isolated cases, this vaccine may cause anaphylactic shock. In such cases, administer 1‰ epinephrine.
Between 2 and 8º C. Do not freeze. Do not expose the product to heat or sunlight.
© Tecnovax 2025
We are a biotechnology company with more than twenty years of experience in the development, production and global commercialization of new vaccines and immunotherapies to protect animal life and productivity.
We are a biotechnology company with more than twenty years of experience in the development, production and global commercialization of new vaccines and immunotherapies to protect animal life and productivity.